Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Business
  • Education
Washingtoner

Longevity Academy Announces J.P. Medved of Longevity Advice as Next Guest in the Longevity Leaders
Washingtoner/10334712

Trending...
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
Founder of Longevity Advice to discuss evidence-based life extension, translating longevity science for everyday people, and the growing movement to extend healthy human lifespan

BELLEVUE, Wash. - Washingtoner -- Longevity Academy is pleased to announce that J.P. Medved, co-founder of Longevity Advice, will be the featured guest in the next installment of the Longevity Leaders Project, an ongoing interview series exploring the people, ideas, organizations, and innovations shaping the future of human longevity.

Medved co-founded Longevity Advice, an educational platform dedicated to helping people understand the rapidly evolving science of extending healthy human lifespan.

Unlike longevity resources written primarily for researchers and clinicians, Longevity Advice was created to make longevity science understandable and useful to people without scientific or medical backgrounds. The platform examines topics ranging from nutrition, exercise, supplements, and biological-age measurement to emerging developments across the broader life-extension field.

A core principle behind Longevity Advice is that longevity recommendations should be grounded in rigorous, peer-reviewed scientific evidence rather than hype, pseudoscience, or unsubstantiated claims.

Medved's interest in radical life extension began as a teenager and was fueled in part by his fascination with science fiction and the possibility of dramatically longer human lives. After leaving his career in content marketing, he began investigating many of the questions surrounding longevity science that he had accumulated over the years.

More on Washingtoner
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • Spokane: City Details Veterans Day Schedule
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category

That research ultimately helped inspire Longevity Advice.

Today, the platform explores practical questions confronting anyone interested in longevity: What kinds of exercise may best support a longer life? Which foods and dietary patterns have the strongest evidence behind them? How can individuals measure biological aging? Which supplements deserve serious consideration—and which claims are mostly hype? And how might new discoveries eventually change what is possible for human lifespan?

During the upcoming Longevity Leaders Project interview, Medved and Longevity Academy will explore these questions as well as the larger challenge of translating a complex and fast-moving scientific field into information ordinary people can understand and act upon.

The conversation is expected to explore:
  • How J.P. Medved became interested in radical life extension and ultimately launched Longevity Advice
  • The mission behind Longevity Advice and the audience it serves
  • How the platform evaluates scientific evidence and separates credible longevity research from hype
  • The most important longevity interventions people can consider today
  • The role of nutrition, exercise, supplements, biomarkers, and self-measurement in longevity
  • How the longevity movement has evolved since Longevity Advice was founded
  • Emerging technologies and research that could reshape healthy aging
  • The growth of the global longevity community and ecosystem
  • Where Medved believes the field may be headed over the next decade
  • What individuals interested in living longer, healthier lives should be paying attention to now

Part of the Longevity Leaders Project

More on Washingtoner
  • Washington Nurse Introduces Nightingale Care Hub to Help Families Organize Care
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Flags Lowered for Spokane County Sheriff Deputies
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand

The Longevity Leaders Project, created by Longevity Academy, features conversations with entrepreneurs, researchers, executives, innovators, and thought leaders working across the rapidly expanding longevity ecosystem.

Rather than focusing only on individual products or technologies, the series examines the people behind longevity innovation—the problems they are trying to solve, the lessons they have learned, and their vision for the future of human health and lifespan.

Previous Longevity Leaders Project conversations have featured leaders from organizations including Global Health Atlas, JouleFit, BrainBoosters of America, and Respira Global.

The interview with J.P. Medved continues the project's mission of documenting the people and organizations helping transform longevity from an emerging scientific field into a global movement.

Learn more about Longevity Advice at https://www.longevityadvice.com/.

Learn more at https://longevityacademy.us/

Source: Longevity Academy
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
  • The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
  • AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
  • Spokane: Mayor Brown Introduces 2027-2028 Budget Proposal
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 237
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 201
  • Final Week to Register for Free Spokane Community Conference - 187
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 173
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 132
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 123
  • Kent Youth and Family Services Announces Sale of Watson Manor - 113
  • Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX - 107
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 107
  • Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon

Similar on Washingtoner

  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute